Pyxis Diagnostics

AI-powered Cancer Diagnostics Platform for Predicting Immuno-oncology Drug Response

Health Tech & Life Sciences
Non Active, Nov 2025 ceased to operate
Seed Jerusalem Founded 2019
LinkedIn
Total raised
$1.2M
Last: Seed 2019-09
Stage
Seed
Founded
2019
Headcount
4
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Pyxis Diagnostics is developing an AI-powered cancer diagnostics platform for predicting immuno-oncology (IO) drug response. The company's platform can predict IO drug response for many cancer types. It can also suggest alternative treatment routes in cases when the predicted drug response is low, improving the quality of life of oncological patients. Biological data collected from fresh tumor samples (using cell sorting, next-generation genetic sequencing, and proteomics), enables deep characterization of the cancer cell, different immune cells, and stromal cells. This profound analysis allows for the delineation of the cellular suppressive network (CSN) formed within the tumor microenvironment. Machine-learning algorithms can then be used for classification of responders based on differential CSN patterns. Pyxis Diagnostics aims to improve outcomes for patients and increase success rates of immunotherapies both in clinics and during the drug-development process.

Funding history · 1 round · $1.2M total

2019-09
Seed $1.2M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Pyxis Diagnostics' primary focus?
Pyxis Diagnostics is developing an AI-powered cancer diagnostics platform designed to predict immuno-oncology (IO) drug response and suggest alternative treatment routes for various cancer types.
When was Pyxis Diagnostics founded?
Pyxis Diagnostics was founded in April 2019.
What is the current operational status of Pyxis Diagnostics?
Pyxis Diagnostics is currently inactive, having ceased operations in November 2025.
How much funding has Pyxis Diagnostics raised in total?
Pyxis Diagnostics has raised a total of $1,200,000 USD.
When did Pyxis Diagnostics complete its last funding round and who were the investors?
Pyxis Diagnostics completed a Seed funding round in September 2019. Investors included Israel Innovation Authority, Vincent Tchenguiz, and VLX Ventures.
How many employees did Pyxis Diagnostics have?
Pyxis Diagnostics had 4 employees.
Where is Pyxis Diagnostics headquartered?
Pyxis Diagnostics is headquartered in Jerusalem, Israel.
Who are the founders of Pyxis Diagnostics?
The founders of Pyxis Diagnostics include Ravit Geva, Ilan Volovitz, Reut Yosef, Aviv De Morgan, Avia Zisso, and Bar Nathansohn.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine LearningBiologicals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

clinical-trialsbiomarkersdiagnosticsimmunotherapypharma-companiesoncologyhospitalsmachine-learningbioinformaticscell-therapydigital-healthcareartificial-intelligencecancerbiotechnology